p38 alpha, p Tyr182 Antibody, Novus Biologicals™

p38 (p Tyr182)

Polyclonal

Unconjugated

PBS [pH 7.4] containing 150mM NaCl, and 50% glycerol (without Mg2+ and Ca2+) with 0.02% Sodium Azide

CSAID-binding protein, Csaids binding protein, CSBP, CSBP1MAX-interacting protein 2, CSBP2, CSPB1, cytokine suppressive inflammatory drug binding protein, Cytokine suppressive inflammatory drug-binding protein, EC 2.7.11, EC 2.7.11.24, EXIP, MAP kinase 14, MAP kinase MXI2, MAP kinase p38 alpha, MAPK 14, mitogen-activated protein kinase 14, Mitogen-activated protein kinase p38 alpha, Mxi2, p38, p38 MAP kinase, p38 mitogen activated protein kinase, p38ALPHA, p38alpha Exip, PRKM14, PRKM15, RK, SAPK2A, stress-activated protein kinase 2A

Rabbit

43 kDa

0.025 mL

Cancer, Cell Cycle and Replication, Immunology, Innate Immunity, MAP Kinase Signaling, Phospho Specific, Protein Kinase, Signal Transduction

1432

Rat, Human, Mouse

IgG

Immunohistochemistry (Paraffin), Western Blot, Immunohistochemistry

1.0 mg/mL

Western Blot 1:500-1:1000, Immunohistochemistry 1:50-1:100, Immunohistochemistry-Paraffin 1:50-1:100

Q16539

MAPK14

The antiserum was produced against synthesized phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyrosine 182 (T-G-YP-V-A).

Affinity Purified

RUO

Primary

p38 MAPK (specific to Phospho-Tyr182) detects endogenous levels of P38MAPK only when phosphorylated at tyrosine 182.

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.